A 41-year-old Asian woman with bilateral renal angiomyolipomas (AML) was incidentally identified to have a balanced translocation, 46,XX,t(11;12)(p15.4;q15). She had no other features or family history to suggest a diagnosis of tuberous sclerosis. Her healthy daughter had the same translocation and no renal AML at the age of 3 years. Whole-genome sequencing was performed on genomic maternal DNA isolated from blood. A targeted de novo assembly was then conducted with ABySS for chromosomes 11 and 12. Sanger sequencing was used to validate the translocation breakpoints. As a result, genomic characterization of chromosomes 11 and 12 revealed that the 11p breakpoint disrupted the NUP98 gene in intron 1, causing a separation of the promoter and transcription start site from the rest of the gene. The translocation breakpoint on chromosome 12q was located in a gene desert. NUP98 has not yet been associated with renal AML pathogenesis, but somatic NUP98 alterations are recurrently implicated in hematological malignancies, most often following a gene fusion event. We also found evidence for complex structural events involving chromosome 12, which appear to disrupt the TDG gene. We identified a TDGP1 partially processed pseudogene at 12p12.1, which adds complexity to the de novo assembly. In conclusion, this is the first report of a germline constitutional structural chromosome rearrangement disrupting NUP98 that occurred in a generally healthy woman with bilateral renal AML.

Keywords:
Balanced translocation, Pseudogene, Renal angiomyolipomas, Tuberous sclerosis, Whole-genome sequencing
1.
Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, et al: DECIPHER: database of chromosomal imbalance and phenotype in humans using Ensembl resources. Am J Hum Genet 84:524-533 (2009).
2.
Fittschen A, Wendlik I, Oeztuerk S, Kratzer W, Akinli AS, et al: Prevalence of sporadic renal angiomyolipoma: a retrospective analysis of 61,389 in- and out-patients. Abdom Imaging 39:1009-1013 (2014).
3.
Fusco A, Fedele M: Roles of HMGA proteins in cancer. Nat Rev Cancer 7:899-910 (2007).
4.
Geraghty PM, Sankarasharma D, Shiomi T, Chada KK, D'Armiento J: Activation of the HMGA2 pathway is necessary in TSC2 associated-mesenchymal tumorigenesis and tuberin positive lymphangiomyomatosis. American Thoracic Society International Conference: A2096 (2010), available at
https://doi.org/10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A2096
.
5.
Gilissen C, Hehir Kwa JY, Thung DT, van de Vorst M, van Bon BW, et al: Genome sequencing identifies major causes of severe intellectual disability. Nature 511:344-347 (2014).
6.
Gough SM, Slape CI, Aplan PD: NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 118:6247-6257 (2011).
7.
Ho H, Skaist AM, Pallavajjala A, Yonescu R, Batista D, et al: NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells. Leukemia Res 45:1-7 (2016).
8.
Huang N, Lee I, Marcotte EM, Hurles ME: Characterizing and predicting haploinsufficiency in the human genome. PLoS Genet 6:e1001154 (2010).
9.
Józwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J: Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 15:652-659 (2000).
10.
Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al: The human genome browser at UCSC. Genome Res 12:996-1006 (2002).
11.
Kersey PJ, Allen JE, Armean I, Boddu S, Bolt BJ, et al: Ensembl Genomes 2016: more genomes, more complexity. Nucleic Acids Res 44:D574-D580 (2016).
12.
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, et al: Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285-291 (2016).
13.
Li H, Durbin R: Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26:589-595 (2010).
14.
MacDonald JR, Ziman R, Yuen RK, Feuk L, Scherer SW: The database of genomic variants: a curated collection of structural variation in the human genome. Nucleic Acids Res 42:D986-D992 (2013).
15.
Nielsen J, Wohlert M: Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Århus, Denmark. Hum Genet 87:81-83 (1991).
16.
O'Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, et al: Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res 44:D733-D745 (2015).
17.
Ottaviani D, LeCain M, Sheer D: The role of microhomology in genomic structural variation. Trends Genet 30:85-94 (2014).
18.
Rabenou RA, Charles HW: Differentiation of sporadic versus tuberous sclerosis complex-associated angiomyolipoma. Am J Roentgenol 205:292-301 (2015).
19.
Robertson G, Schein J, Chiu R, Corbett R, Field M, et al: De novo assembly and analysis of RNA-seq data. Nat Methods 7:909-912 (2010).
20.
Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, et al: Integrative genomics viewer. Nat Biotechnol 29:24-26 (2011).
21.
Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, et al: ENCODE data in the UCSC genome browser: year 5 update. Nucleic Acids Res 41:D56-D63 (2012).
22.
Saw J, Curtis DJ, Hussey DJ, Dobrovic A, Aplan PD, Slape CI: The fusion partner specifies the oncogenic potential of NUP98 fusion proteins. Leukemia Res 37:1668-1673 (2013).
23.
Simpson JT, Wong K, Jackman SD, Schein JE, Jones SJM, Birol I: ABySS: a parallel assembler for short read sequence data. Genome Res 19:1117-1123 (2009).
24.
Thway K, Fisher C: PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol 19:359-368 (2015).
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.